Show simple item record

Localized lentivirus delivery via peptide interactions

dc.contributor.authorSkoumal, Michael
dc.contributor.authorSeidlits, Stephanie
dc.contributor.authorShin, Seungjin
dc.contributor.authorShea, Lonnie
dc.date.accessioned2016-09-17T23:54:31Z
dc.date.available2017-12-01T21:54:11Zen
dc.date.issued2016-09
dc.identifier.citationSkoumal, Michael; Seidlits, Stephanie; Shin, Seungjin; Shea, Lonnie (2016). "Localized lentivirus delivery via peptide interactions." Biotechnology and Bioengineering 113(9): 2033-2040.
dc.identifier.issn0006-3592
dc.identifier.issn1097-0290
dc.identifier.urihttps://hdl.handle.net/2027.42/133589
dc.description.abstractGene delivery from biomaterial scaffolds has been employed to induce the expression of tissue inductive factors for applications in regenerative medicine. The delivery of viral vectors has been described as reflecting a balance between vector retention and release. Herein, we investigated the design of hydrogels in order to retain the vector at the material in order to enhance transgene expression. Poly(ethylene‐glycol) (PEG) hydrogels were modified with poly‐l‐lysine (PLL) to non‐covalently bind lentivirus. For cells cultured on the hydrogels, increasing the PLL molecular weight from 1 to 70 kDa led to increased transgene expression. The incubation time of the virus with the hydrogel and the PLL concentration modulated the extent of virus adsorption, and adsorbed virus had a 20% increase in the half‐life at 37°C. Alternatives to high molecular weight PLL were identified through phage display technology, with peptide sequences specific for the VSV‐G ectodomain, an envelope protein pseudotyped on the virus. These affinity peptides could easily be incorporated into the hydrogel, and expression was increased 20‐fold relative to control peptide, and comparable to levels observed with the high molecular weight PLL. The modification of hydrogels with affinity proteins or peptides to bind lentivirus can be a powerful strategy to enhance and localized transgene expression. Biotechnol. Bioeng. 2016;113: 2033–2040. © 2016 Wiley Periodicals, Inc.By conjugating affinity peptides to poly(ethylene‐glycol) (PEG) hydrogels, lentiviral vectors were non‐covalently bound to the hydrogel surface. Poly‐l‐lysine (PLL) and short, 12‐amino acid sequences identified via phage display, were analyzed. The modification of hydrogels with affinity proteins or peptides to bind lentivirus can be a powerful strategy to enhance and localized transgene expression.
dc.publisherWiley Periodicals, Inc.
dc.publisherInTech
dc.subject.otherlocalized gene delivery
dc.subject.otherlentivirus
dc.subject.otherpolylysine
dc.subject.otherphage display
dc.titleLocalized lentivirus delivery via peptide interactions
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelStatistics and Numeric Data
dc.subject.hlbsecondlevelNatural Resources and Environment
dc.subject.hlbsecondlevelBiological Chemistry
dc.subject.hlbsecondlevelMathematics
dc.subject.hlbsecondlevelEcology and Evolutionary Biology
dc.subject.hlbtoplevelHealth Sciences
dc.subject.hlbtoplevelSocial Sciences
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133589/1/bit25961.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133589/2/bit25961_am.pdf
dc.identifier.doi10.1002/bit.25961
dc.identifier.sourceBiotechnology and Bioengineering
dc.identifier.citedreferencePadmashali RM, Andreadis ST. 2011. Engineering fibrinogen‐binding VSV‐G envelope for spatially‐ and cell‐controlled lentivirus delivery through fibrin hydrogels. Biomaterials 32 ( 12 ): 3330 – 3339.
dc.identifier.citedreferenceBoehler RM, Shin S, Fast AG, Gower RM, Shea LD. 2013. A PLG/HAp composite scaffold for lentivirus delivery. Biomaterials 34 ( 21 ): 5431 – 5438.
dc.identifier.citedreferenceBukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubei A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M. 1993. A nuclear localization signal within HIV‐1 matrix protein that governs infection of non‐dividing cells. Nature 365 ( 14 ): 666 – 669.
dc.identifier.citedreferenceChamarthy SP, Jia L, Kovacs JR, Anderson KR, Shen H, Firestine SM, Meng WS. 2004. Gene delivery to dendritic cells facilitated by a tumor necrosis factor alpha‐competing peptide. Mol Immunol 41 ( 8 ): 741 – 749.
dc.identifier.citedreferenceDavis HE, Rosinski M, Morgan JR, Yarmush ML. 2004. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 86: 1234 – 1242.
dc.identifier.citedreferenceDeguchi Y, Kurihara A, Pardridge WM. 1998. Rentention of biologic activity of human epidermal growth factor following conjugation to a blood–brain barrier druge delivery vector via an extended poly(ethylene glycol) linker. Bioconjug Chem 10: 32 – 37.
dc.identifier.citedreferenceDore JM, Morard F, Vita N, Wijdenes J. 1998. Identification and location on syndecan‐1 core protein of the epitopes of B‐B2 and B‐B4 monoclonal antibodies. FEBS Lett 426: 67 – 70.
dc.identifier.citedreferenceDull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third‐generation lentivirus vector with a conditional packaging system. J Virol 72 ( 11 ): 8463 – 8471.
dc.identifier.citedreferenceHardy B, Raiter A, Weiss C, Kaplan B, Tenenbaum A, Battler A. 2007. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions. Peptides 28 ( 3 ): 691 – 701.
dc.identifier.citedreferenceHigashikawa F, Chang L. 2001. Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280 ( 1 ): 124 – 131.
dc.identifier.citedreferenceJen MC, Baler K, Hood AR, Shin S, Shea LD, Ameer GA. 2013. Sustained, localized transgene expression mediated from lentivirus‐loaded biodegradable polyester elastomers. J Biomed Mater Res A 101 ( 5 ): 1328 – 1335.
dc.identifier.citedreferenceMiura Y, Sasao Y, Kamihira M, Sakaki A, Iijima S, Kobayashi K. 2004. Peptides binding to a Gb3 mimic selected from a phage library. Biochim Biophys Acta 1673 ( 3 ): 131 – 138.
dc.identifier.citedreferenceMummert ME, Mohamadzadeh M, Mummert D, Mizumoto N. 2000. Development of a peptide inhibitor of hyaluronan‐mediated leukocyte trafficking. J Exp Med 192 ( 6 ): 769 – 779.
dc.identifier.citedreferenceNaldini L, Blomer U, Gage FH, Trono D, Verma IM. 1996. Efficient transfer, integration, and sustained long‐term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382 – 11388.
dc.identifier.citedreferencePhillips JE, Burns KL, Le Doux JM, Guldberg RE, Garcia AJ. 2008. Engineering graded tissue interfaces. Proc Natl Acad Sci USA 105 ( 34 ): 12170 – 12175.
dc.identifier.citedreferenceRaeber GP, Lutolf MP, Hubbell JA. 2005. Molecularly engineered PEG hydrogels: A novel model system for proteolytically mediated cell migration. Biophys J 89 ( 2 ): 1374 – 1388.
dc.identifier.citedreferenceRaut SD, Lei P, Padmashali RM, Andreadis ST. 2010. Fibrin‐mediated lentivirus gene transfer: Implications for lentivirus microarrays. J Control Release 144 ( 2 ): 213 – 220.
dc.identifier.citedreferenceRoche S, Rey FA, Gaudin Y, Bressanelli S. 2007. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 315 ( 5813 ): 843 – 848.
dc.identifier.citedreferenceRodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L. 1999. Screening of a library of phage‐displayed peptides identifies human Bcl‐2 as a taxol‐binding protein. J Mol Biol 285: 197 – 203.
dc.identifier.citedreferenceRomanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O’Riordan CR. 1999. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther 10: 2615 – 2626.
dc.identifier.citedreferenceRozinov MN, Nolan GP. 1998. Evolution of peptides that modulate the spectral qualities of bound, small‐molecule fluorophores. Chem Biol 5: 713 – 728.
dc.identifier.citedreferenceSamoylova TI, Smith BF. 1999. Elucidation of muscle‐binding peptides by phage display screening. Muscle Nerve 22 ( 4 ): 460 – 466.
dc.identifier.citedreferenceShen Y, Muramatsu S‐I, Ikeguchi K, Fujimoto K‐I, Fan D‐S, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, Urano F, Suzuki T, Ichinose H, Nagatsu T, Monahan J, Nakano I, Ozawa K. 2000. Triple transduction with adeno‐associated virus vectors expressing tyrosine hydroxylase, aromatic‐L‐amino‐acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson’s disease. Hum Gene Ther 11: 1509 – 1519.
dc.identifier.citedreferenceShepard JA, Virani FR, Goodman AG, Gossett TD, Shin S, Shea LD. 2012. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 33 ( 30 ): 7412 – 7421.
dc.identifier.citedreferenceShin S, Shea LD. 2010. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther 18 ( 4 ): 700 – 706.
dc.identifier.citedreferenceShin S, Tuinstra HM, Salvay DM, Shea LD. 2010. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 31 ( 15 ): 4353 – 4359.
dc.identifier.citedreferenceThomas AM, Seidlits SK, Goodman AG, Kukushliev TV, Hassani DM, Cummings BJ, Anderson AJ, Shea LD. 2014. Sonic hedgehog and neurotrophin‐3 increase oligodendrocyte numbers and myelination after spinal cord injury. Integr Biol (Camb) 6 ( 7 ): 694 – 705.
dc.identifier.citedreferenceTolmachov OE, Tolmachova T, Al‐Allaf FA. 2011. Designing lentiviral gene vectors. Designing gene vectors. Rijeka, Croatia: InTech. p 263 – 284.
dc.identifier.citedreferenceZhang B, Metharom P, Jullie H, Ellem KA, Cleghorn G, West MJ, Wei MQ. 2004. The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events. Genet Vaccines Ther 2 ( 1 ): 6.
dc.identifier.citedreferenceZhang X, Goncalves R, Mosser D. 2008. The isolation and characterization of murine macrophages. Curr Protoc Immunol 1: 1 – 18.
dc.identifier.citedreferenceLentz TB, Gray SJ, Samulski RJ. 2012. Viral vectors for gene delivery to the central nervous system. Neurobiol Dis 48 ( 2 ): 179 – 188.
dc.identifier.citedreferenceLewis P, Hensel M, Emerman M. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11 ( 8 ): 3053 – 3058.
dc.identifier.citedreferenceLewis PF, Emerman M. 1993. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68 ( 1 ): 510 – 516.
dc.identifier.citedreferenceLuk KDK, Chen Y, Cheung KMC, Kung H‐F, Lu WW, Leong JCY. 2003. Adeno‐associated virus‐mediated bone morphogenetic protein‐4 gene therapy for in vivo bone formation. Biochem Biophys Res Commun 308 ( 3 ): 636 – 645.
dc.identifier.citedreferenceLuo D, Saltzman MW. 2000. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 18: 893 – 895.
dc.identifier.citedreferenceMenendez A, Scott JK. 2005. The nature of target‐unrelated peptides recovered in the screening of phage‐displayed random peptide libraries with antibodies. Anal Biochem 336 ( 2 ): 145 – 157.
dc.identifier.citedreferenceAbordo‐Adesida E, Follenzi A, Barcia C, Sciascia S, Castro MG, Naldini L, Lowenstein PR. 2005. Stability of lentiviral vector‐mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 16 ( 6 ): 741 – 751.
dc.identifier.citedreferenceAdey NB, Mataragnon AH, Rider JE, Carter JM, Kay BK. 1995. Characterization of phage that bind plastic from phage‐displayed random peptide libraries. Gene 156: 27 – 31.
dc.identifier.citedreferenceBengali Z, Rea JC, Gibly RF, Shea LD. 2009. Efficacy of immobilized polyplexes and lipoplexes for substrate‐mediated gene delivery. Biotechnol Bioeng 102 ( 6 ): 1679 – 1691.
dc.identifier.citedreferenceBinetruy‐Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouet J, Derbin C, Perret G, Mazie JC. 2000. Identification of a peptide blocking vascular endothelial growth factor (VEGF)‐mediated angiogenesis. EMBO J 19 ( 7 ): 1525 – 1533.
dc.identifier.citedreferenceBirkenmeier G, Osman AA, Kopperschläger G, Thomas M. 1997. Epitope mapping by screening of phage display libraries of a monoclonal antibody directed against the receptor binding domain of human α2‐macroglobulin. FEBS Lett 416 ( 2 ): 193 – 196.
dc.identifier.citedreferenceBluebird Bio. 2013 –2018. A phase 2/3 study of the efficacy and safety of hematopoietic stem cells transduced with Lenti‐D lentiviral vector for the treatment of Childhood Cerebral Adrenoleukodystrophy (CCALD). ClinicalTrials.gov. NLM Identifier: NCT01896102.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.